1. The PHMNP is caring for a patient who would benefit from nicotine cholinergic, serotonin 3, or glycine receptors. What kind of agent does the PHMNP want to prescribe for this patient?
A.
Ligand-gated ion channels with a pentameric structure
B.
Ligand-gated ion channels with a tetrameric structure
C.
Voltage-sensitive ion channels
D.